Arianna Calcinotto

Title: Arianna Calcinotto: Innovator in Prostate Cancer Treatment

Introduction

Arianna Calcinotto is a prominent inventor based in Bellinzona, Switzerland. She has made significant contributions to the field of oncology, particularly in the treatment of prostate cancer. Her innovative approaches aim to improve the lives of patients suffering from this challenging disease.

Latest Patents

Arianna holds a patent for her invention titled "Methods of treating androgen deprivation therapy resistant prostate cancer." This patent outlines a method of treatment that involves administering a therapeutically effective amount of an inhibitor of IL-23 and/or an inhibitor of IL-23R to a mammalian patient in need. The invention specifically addresses castration-resistant prostate cancer (CRPC) and includes the use of anti-IL-23 antibodies such as risankizumab, guselkumab, or tildrakizumab. Additionally, the method may involve the administration of androgen deprivation therapy, such as enzalutamide. The patent also provides a method for predicting the development of resistance to androgen deprivation therapy in prostate cancer patients.

Career Highlights

Arianna has worked with esteemed organizations, including the Fondazione per l'Istituto Oncologico di Ricerca and The Institute of Cancer Research: Royal Cancer Hospital. Her work in these institutions has allowed her to advance her research and contribute to the understanding of prostate cancer treatment.

Collaborations

Arianna has collaborated with notable professionals in her field, including Andrea Alimonti and Johann De Bono. These partnerships have further enriched her research and innovation efforts.

Conclusion

Arianna Calcinotto is a trailblazer in the field of prostate cancer treatment, with her innovative patent addressing critical challenges in the management of the disease. Her contributions continue to impact the lives of many patients, showcasing the importance of research and innovation in healthcare.